IL117670A - Low dose ridogrel formulations for treatment of inflammatory bowel diseases - Google Patents

Low dose ridogrel formulations for treatment of inflammatory bowel diseases

Info

Publication number
IL117670A
IL117670A IL11767096A IL11767096A IL117670A IL 117670 A IL117670 A IL 117670A IL 11767096 A IL11767096 A IL 11767096A IL 11767096 A IL11767096 A IL 11767096A IL 117670 A IL117670 A IL 117670A
Authority
IL
Israel
Prior art keywords
ridogrel
formulations
treatment
inflammatory bowel
low dose
Prior art date
Application number
IL11767096A
Other languages
English (en)
Other versions
IL117670A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL117670A0 publication Critical patent/IL117670A0/xx
Publication of IL117670A publication Critical patent/IL117670A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
IL11767096A 1995-03-28 1996-03-27 Low dose ridogrel formulations for treatment of inflammatory bowel diseases IL117670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28

Publications (2)

Publication Number Publication Date
IL117670A0 IL117670A0 (en) 1996-07-23
IL117670A true IL117670A (en) 2000-02-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11767096A IL117670A (en) 1995-03-28 1996-03-27 Low dose ridogrel formulations for treatment of inflammatory bowel diseases

Country Status (10)

Country Link
EP (1) EP0817631A2 (fr)
JP (1) JPH10511097A (fr)
AR (1) AR002727A1 (fr)
AU (1) AU5397496A (fr)
CA (1) CA2215160A1 (fr)
HU (1) HUP9900309A3 (fr)
IL (1) IL117670A (fr)
NO (1) NO974486D0 (fr)
WO (1) WO1996030016A2 (fr)
ZA (1) ZA962461B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
EP1370244A1 (fr) * 2001-03-12 2003-12-17 Novo Nordisk A/S Nouveaux comprimes et gelules et procede de preparation correspondant
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
PT2396081T (pt) 2009-02-16 2017-07-11 Nogra Pharma Ltd Compostos alquilamido e suas utilizações
CA2864059C (fr) 2012-02-09 2020-04-28 Nogra Pharma Limited Methodes de traitement de la fibrose
BR112014026160A2 (pt) 2012-04-18 2017-07-18 Nogra Pharma Ltd métodos para tratar intolerância à lactose
WO2017046343A1 (fr) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions pour une administration par voie rectale dans le traitement de la colite ulcéreuse et leurs procédés d'utilisation
EA202192207A1 (ru) 2019-02-08 2021-10-27 Ногра Фарма Лимитед Способ получения 3-(4'-аминофенил)-2-метоксипропионовой кислоты и ее аналогов и промежуточных соединений

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
JPH10511097A (ja) 1998-10-27
EP0817631A2 (fr) 1998-01-14
ZA962461B (en) 1997-09-29
WO1996030016A2 (fr) 1996-10-03
HUP9900309A2 (hu) 1999-05-28
CA2215160A1 (fr) 1996-10-03
WO1996030016A3 (fr) 1997-01-30
NO974486L (no) 1997-09-29
AR002727A1 (es) 1998-04-29
NO974486D0 (no) 1997-09-29
AU5397496A (en) 1996-10-16
HUP9900309A3 (en) 1999-11-29
IL117670A0 (en) 1996-07-23
MX9707394A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
IL161833A0 (en) Pharmaceutical compositions and usethereof for thetreatment of psychotic diseases
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUP9900950A3 (en) Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease
EP0942742A4 (fr) Compositions therapeutiques destinees au traitement du cancer
EP0759750A4 (fr) Compositions pour le traitement de maladies inflammatoires chroniques
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
AU6590896A (en) Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HUP0001084A3 (en) Modified release oral pharmaceutical composition containing 5-asa for the treatment of bowel diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
IL117670A (en) Low dose ridogrel formulations for treatment of inflammatory bowel diseases
GR3035622T3 (en) Azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel disease
HUP9900147A2 (hu) Terápiás szerek és autoimmun betegségek kezelésére alkalmas gyógyszerkészítmények
AU2886292A (en) Compositions and methods for treatment of epstein-barr virus-associated diseases
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
HU9204028D0 (en) Medical preparative for treatment of diseases of mamma
GB2300807B (en) Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease
ZA95908B (en) A synergistic formulation for treatment of rheumatic diseases
HUP9702408A3 (en) Use of 5-phenyloxazolidin-2-one derivatives for the preparation of pharmaceutical compositions treating diseases requiring tumour necrosis factor (tnf) inhibition
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
EP0796105A4 (fr) Compositions pharmaceutiques destinees au traitement de maladies auto-immunes et comprenant l'oligomere b de la toxine de pertussis ou ses sous-unites
IL114923A0 (en) Chintin extract for treatment of skin disease
ZA968902B (en) Methods and compositions for treatment of diseases

Legal Events

Date Code Title Description
FF Patent granted